Related Experiment Video
Updated: Sep 25, 2025

09:13
Two-dimensional Porcine Intestinal Organoids Reflecting the Physiological Properties of Native Gut
Published on: January 31, 2025
628
Modulating Effect of Paeonol on Piglets With Ulcerative Colitis.
Shanshan Wang1, Miaomiao Bai2, Qingyan Shu3
1Institute of Animal Nutrition, Northeast Agricultural University, Harbin, China.
Frontiers in Nutrition
|May 2, 2022
Summary
Paeonol (Pae) effectively alleviates dextran sodium sulfate-induced ulcerative colitis in piglets by improving intestinal barrier function and growth performance. This study highlights Pae
Area of Science:
- Veterinary Medicine
- Gastroenterology
- Pharmacology
Background:
- Piglet enteritis poses a significant challenge in modern swine production, necessitating urgent therapeutic solutions.
- Paeonol (Pae), a compound with recognized medicinal value, is explored as a novel treatment for gastrointestinal disorders.
Purpose of the Study:
- To investigate the regulatory mechanisms of Paeonol in mitigating dextran sodium sulfate (DSS)-induced ulcerative colitis (UC) in weaned piglets.
- To evaluate the effects of Paeonol on intestinal barrier function, inflammatory responses, gut microbiota, and growth performance in piglets with UC.
Main Methods:
- Thirty-six weaned piglets were divided into six groups: control, DSS-induced UC, and four treatment groups (Paeonol at varying doses or mesalazine).
- Ulcerative colitis was induced using DSS, followed by oral administration of Paeonol or mesalazine for 27 days.
- Key parameters assessed included growth performance (ADFI, ADG, F/G), intestinal barrier markers (Occludin, ZO-1 mRNA), inflammatory cytokines (TGF-β, IL-4), apoptosis markers (Caspase-8), gut microbiota composition, and short-chain fatty acids.
Main Results:
- Paeonol administration significantly improved average daily gain (ADG), average daily feed intake (ADFI), and reduced the feed-to-gain ratio (F/G).
- Paeonol enhanced the expression of intestinal tight junction proteins (Occludin, ZO-1) and modulated inflammatory factors (TGF-β, IL-4).
- Paeonol treatment altered gut microbiota composition, increasing beneficial bacteria like Prevotella and Firmicutes, while reducing Campilobacterota, and elevated beneficial short-chain fatty acids (propionic, butyric, valeric acids).
Conclusions:
- Paeonol demonstrates significant therapeutic potential in alleviating DSS-induced ulcerative colitis in piglets.
- Paeonol exerts its effects by enhancing intestinal barrier integrity, balancing inflammatory responses, modulating gut microbiota, and improving growth performance.
- Paeonol represents a promising natural compound for managing piglet enteritis and promoting gut health in swine production.

